AbbVie to Advance Once-Daily ABT-494 to Phase 3 in Rheumatoid Arthritis by Year-End

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/30/2026

1. META
2. MSFT
3. V
4. PYPL
5. KLAC
6. SPY
7. STX
8. CSGP
9. BE
10. SWKS

Go back to AbbVie to Advance Once-Daily ABT-494 to Phase 3 in Rheumatoid Arthritis by Year-End
AbbVie (NYSE: ABBV) Delayed: 263.30 +0.10 (0.04%)
Previous Close $263.20    52 Week High $68.12 
Open $264.21    52 Week Low $50.71 
Day High $267.47    P/E 57.11 
Day Low $262.76    EPS $4.61 
Volume 5,564,076